Published in Br Med J (Clin Res Ed) on January 21, 1984
Do beta blockers cause arthropathy? A case control study. Br Med J (Clin Res Ed) (1985) 0.75
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Case report. Propranolol-induced lupus syndrome? Postgrad Med (1976) 1.64
Systemic lupus erythematosus syndrome induced by pindolol. Br Med J (1979) 1.32
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. Lancet (1983) 1.94
What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis (1989) 1.89
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology (Oxford) (2006) 1.86
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int (1987) 1.62
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs. Br J Rheumatol (1992) 1.43
Methotrexate toxicity induced by acute renal failure. J R Soc Med (2004) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers. Br J Clin Pharmacol (1990) 1.19
N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? Br J Clin Pharmacol (1987) 1.18
Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis (1997) 1.13
Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) (2003) 1.11
Another hazard of gold therapy? Ann Rheum Dis (1982) 1.11
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis (1998) 1.10
Burns because of epilepsy. Br Med J (Clin Res Ed) (1988) 1.10
The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial. Rheumatology (Oxford) (2000) 1.04
Successful treatment of Raynaud's Syndrome with prostacyclin. Thromb Haemost (1981) 1.00
A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology (Oxford) (2002) 0.99
Can treatment really influence the radiological progression of rheumatoid arthritis? Br J Rheumatol (1986) 0.97
Measuring treatment compliance of men with non-gonococcal urethritis receiving oxytetracycline combined with low dose phenobarbitone. Genitourin Med (1988) 0.94
An observer-blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford) (2000) 0.93
The risk of treatment. A study of rheumatoid arthritis patients' attitudes. Br J Rheumatol (1998) 0.92
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Drugs (1986) 0.92
C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) (2008) 0.91
Bone health in patients with fibromyalgia. Rheumatology (Oxford) (2003) 0.90
Reduced steady-state plasma concentrations of chlorpromazine and indomethacin in patients receiving cimetidine. Eur J Clin Pharmacol (1983) 0.89
Non-Hodgkin's lymphoma in rheumatoid arthritis. Ann Rheum Dis (1991) 0.88
Combined phlebography and arthrography in patients with painful swollen calf. Br Med J (Clin Res Ed) (1981) 0.86
Interaction between oral anti-coagulant drugs and non-steroidal anti-inflammatory agents: a review. Scott Med J (1983) 0.86
Gold and penicillamine therapy: is shared care with general practitioners effective and safe? Rheumatol Rehabil (1982) 0.86
The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam. Br J Clin Pharmacol (1987) 0.86
Alternative medicine: cost and subjective benefit in rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 0.84
Chrysotherapy and thrombocytopenia. Ann Rheum Dis (1985) 0.84
Risk taking in patients with rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.83
Reporting compliance in clinical trials. Lancet (1990) 0.82
The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up. Clin Rheumatol (2002) 0.81
Chest wall tenderness is unhelpful in the diagnosis of recurrent chest pain. QJM (2001) 0.81
Investigation of cutaneous microvascular activity and flare response in patients with fibromyalgia syndrome. Rheumatology (Oxford) (2001) 0.80
Spontaneous fractured neck of femur in rheumatoid arthritis: absence of radiographic changes on initial X-ray. Scott Med J (1985) 0.80
Investigation of novel polymorphisms within the 3' region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis. Cytokine (2001) 0.80
Chronic Q fever with mixed cryoglobulinaemia. Ann Rheum Dis (1989) 0.79
Sulphasalazine in the treatment of rheumatoid arthritis. Br J Rheumatol (1997) 0.78
Selection of suitable patients for second-line therapy in rheumatoid arthritis. Br J Rheumatol (1986) 0.77
Vasomotor reactions with gold. Br J Rheumatol (1997) 0.77
The hip or not. J Rheumatol (2001) 0.77
Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study. Scott Med J (2012) 0.77
Corticosteroids in the management of rheumatoid arthritis. Br J Rheumatol (1996) 0.77
Value of test for antinuclear antibodies in rheumatic diseases. Br Med J (Clin Res Ed) (1984) 0.76
Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review. Drugs (1986) 0.76
Second line therapy in rheumatoid arthritis--a four year prospective study. Clin Rheumatol (1985) 0.76
The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisolone. Br J Rheumatol (1993) 0.76
Combination therapy in rheumatoid arthritis. Br J Rheumatol (1991) 0.75
Sjögren's syndrome: a contraindication to levamisole treatment? Br Med J (1977) 0.75
C-reactive protein levels correlate with functional outcome. J Rheumatol (1997) 0.75
Effect of patient population characteristics in assessing the efficacy and toxicity of methotrexate in rheumatoid arthritis: comment on the article by Weinblatt et al. Arthritis Rheum (1995) 0.75
Joint inflammation and erosion: different mechanisms? Br J Rheumatol (1997) 0.75
Interpretation of trials--the other side. Br J Rheumatol (1991) 0.75
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1996) 0.75
Non-steroidal anti-inflammatory therapy for asthma. Lancet (1998) 0.75
Rheumatoid arthritis. Lancet (1995) 0.75
Intermittent cyclophosphamide in refractory rheumatoid arthritis. Br Med J (Clin Res Ed) (1983) 0.75
Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial. Br J Clin Pharmacol (1983) 0.75
Fatal exacerbation of systemic lupus erythematosus after treatment with griseofulvin. Br Med J (Clin Res Ed) (1985) 0.75
Interaction of indomethacin and warfarin. Br Med J (Clin Res Ed) (1982) 0.75
'Acceptable' risk of drug treatment. Br J Clin Pharmacol (1992) 0.75
Sulphasalazine and hepatic transaminases. Ann Rheum Dis (1987) 0.75
Prevalence of genetic haemochromatosis and iron overload in patients attending rheumatology and joint replacement clinics. Scott Med J (2010) 0.75
Drugs and the elderly. Ann Rheum Dis (1991) 0.75
Disappointing results of increasing benzodiazepine dose after the development of anticonvulsant tolerance. J Neurol Neurosurg Psychiatry (1988) 0.75
Adrenal response in rheumatoid arthritis treated with long-term steroids. Eur J Rheumatol Inflamm (1983) 0.75
An inhibitor of complement-mediated prevention of immune precipitation in rheumatoid arthritis--relationship to disease activity and systemic manifestations. Rheumatol Int (1986) 0.75
Electroencephalographic tolerance and abstinence phenomena during repeated alcohol ingestion by nonalcoholics. Science (1981) 0.75
Comfort shoes--a cheaper alternative to surgical shoes in rheumatoid arthritis. Health Bull (Edinb) (1983) 0.75
Liver dysfunction associated with gold therapy for RA. J Rheumatol (1984) 0.75
Have the newer NSAIDS contributed to the management of rheumatoid arthritis? Scott Med J (1985) 0.75
A review of 80 barium meal examinations in patients with rheumatoid arthritis: were they necessary? Br J Clin Pract (1984) 0.75
Screening for new antirheumatic drugs. Br J Rheumatol (1985) 0.75
The giant T-wave. Heart Lung (1976) 0.75
Drug therapy and rheumatoid arthritis. Scott Med J (1985) 0.75
Problems in the clinical evaluation of antirheumatic drugs. Agents Actions Suppl (1980) 0.75
General practitioner assistance with gold and penicillamine therapy of rheumatoid arthritis--a four year prospective study. Scott Med J (1987) 0.75
Unmet need in osteoporosis. Health Bull (Edinb) (2000) 0.75
Sulphasalazine in rheumatoid arthritis. Lancet (1985) 0.75
An unusual case of "giant cell arteritis". Ann Rheum Dis (2004) 0.75
IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs. Biochem Soc Trans (1992) 0.75
Interaction of ibuprofen and warfarin on primary haemostasis. Br J Rheumatol (1989) 0.75
Polymyositis with cardiac manifestations and unexpected immunology. Ann Rheum Dis (2002) 0.75
Non-steroidal anti-inflammatory drugs and the acetabulum. Lancet (1985) 0.75
The treatment of juvenile arthritis. Expert Opin Pharmacother (2001) 0.75